JUN Human shRNA Plasmid Kit (Locus ID 3725)
JUN - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
|Product Name||JUN Human shRNA Plasmid Kit (Locus ID 3725)|
|Synonyms||AP-1; AP1; c-Jun|
|Kit Components||JUN - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 3725). 5µg purified plasmid DNA per constructNon-effective 29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free.|
|Summary||This gene is the putative transforming gene of avian sarcoma virus 17. It encodes a protein which is highly similar to the viral protein, and which interacts directly with specific target DNA sequences to regulate gene expression. This gene is intronless and is mapped to 1p32-p31, a chromosomal region involved in both translocations and deletions in human malignancies. [provided by RefSeq, Jul 2008]|
|shRNA Design||These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, align it with our published shRNA design sequences. If these do not align, please utilize our custom shRNA service|
|Performance Guaranteed||OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at firstname.lastname@example.org. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).
|The use of this RNAi has been cited in the following citations:|
PNAS Plus: Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation
,Lior Blau, Revital Knirsh, Iris Ben-Dror, Sivan Oren, Silke Kuphal, Peter Hau, Martin Proescholdt, Anja-Katrin Bosserhoff, and Lily Vardimon,
PNAS, Oct 2012; 109: E2875 - E2884.